Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for trichomoniasis
Perform Another (Advanced) Search
Related Words: trichomoniasis
10 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Newly Approved Drug Therapies (873) Tindamax, tinidazole, Presutti Laboratories, ...as 3 days. Tinidazole tablets are indicated for the treatment of the following protozoal infections • • Trichomoniasis caused by T. vaginalis in both male and female patients • Giardiasis caused by G. duodenalis ......dosing stregths (250 and 500 mg), and is designed to be taken with food. For trichomoniasis and giardiasis, recommended dosage is a single dose of 2 g. For amebiasis/amebic abscess ...View Page
2. Study Posting (5339) Trial #154742, Women's Health, Bronx, NY ...Exclusion criteria: • Pregnant, breastfeeding, or menopausal. • HIV • Vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. Abnormal Pap ...View Page
3. Study Posting (5339) Trial #154740, Vaginal Infection, Bronx, NY ...criteria: • Pregnant, breastfeeding, or menopausal. • HIV • Concurrent Vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. • Abnormal Pap ...View Page
4. Study Posting (5339) Trial #154741, Genital Herpes, Bronx, NY ...Exclusion criteria: • Pregnant, breastfeeding, or menopausal. • HIV • Vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. Abnormal Pap ...View Page
5. Study Posting (5339) Trial #159890, Women's Health, Bronx, NY ...criteria: • Pregnant, breastfeeding, or menopausal. • HIV. • Concurrent vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. • Positive HSV ...View Page
6. Study Posting (2348) Trial #94809, Herpes Simplex Infections, New York, NY ...time of visit. Concurrent vaginitis, urinary tract infection or sexually transmitted infection including bacterial vaginosis, trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. Intercourse within ...View Page
7. Study Posting (2348) Trial #94802, Herpes Simplex Infections, New York, NY ...weeks. Currently menstruating at time of visit. Concurrent vaginitis, UTI or STI including Bacterial Vaginosis, trichomoniasis, candidiasis, chlamydia, gonorrhea or syphilis within one month prior to or at screening. Intercourse within ...View Page
8. Study Posting (5339) Trial #159891, *Healthy Patient Studies, Bronx, NY ...criteria: • Pregnant, breastfeeding, or menopausal. • HIV. • Concurrent vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. • Positive HSV ...View Page
9. CenterWatch: List of Newly Approved Drug Thearapies ...pneumonia., Approved April 2004 Tindamax, tinidazole ; Presutti Laboratories; For the treatment of microbial infections, including trichomoniasis, giardiasis, and amebiasis, Approved May, 2004 Xifaxan (rifaximin) ; Salix Pharmaceuticals; For the treatment of Travelers ...View Page
10. CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies ...pneumonia., Approved April 2004 Tindamax, tinidazole ; Presutti Laboratories; For the treatment of microbial infections, including trichomoniasis, giardiasis, and amebiasis, Approved May, 2004 Xifaxan (rifaximin) ; Salix Pharmaceuticals; For the treatment of Travelers ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.